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Chen et al., 2013), a higher frequency of attacks (Westling & Öst, 1993) , a greater number of comorbid Axis I diagnoses (Wilson, Sandler, & Asmundson, 1993; Goodwin & Hamilton, 2002; Chen et al., 2013) , and a greater number of agoraphobic behaviors (Wilson et al., 1993; Chen et al., 2013; Berle, Starcevic, Milicevic, Hannan, & Moses, 2010 ). Additionally, one study showed that cognitive features, such as high anxiety sensitivity and agoraphobic fear, were related to later remission of PD (Park et al., 2012) . Researchers comparing early-onset fearful panic attacks to early-onset non-fearful panic attacks found that fearful attacks had a stronger association with increased severity of psychopathology, suicidal ideation, and suicide attempts (Goodwin & Hamilton, 2002) . Studies comparing panic disorder with agoraphobia (PDA) to panic disorder without agoraphobia (PDWA) also suggest that catastrophic cognitions may be involved in the development or maintenance of agoraphobia, a diagnosis that has been associated with increased cognitive biases than PDWA (Telch, Brouillard, Telch, Agras, & Taylor, 1989; Iketani et al., 2002) . This is consistent with research indicating that PDA is more severe than PDWA (Grant et al., 2006) . Given that the majority of past research indicates a relationship between cognitive fear during panic and higher symptom severity, one can infer that cognitive symptoms in PD do not merely serve etiological explanations of panic, but are also indicative of higher psychiatric impairment as a result of PD.
Despite ample evidence that cognitive distress accompanying physical symptoms of panic indicates an acute presentation of PD, few studies have examined the clinical significance of individual panic-cognitions. It makes intuitive sense that 'fear of dying' (FOD) would be associated with severity;
given the extremity of this thought and the notion that PD is characterized by fearing the consequences of anxiety symptoms, rather than another phobic stimulus (Murray, McHugh, & Otto, 2010) . Indeed, certain findings suggest FOD during panic attacks may be a useful detector of severe panic attacks (Craske et al., 2010) . Authors examining clinical severity difference in patients with non-fearful panic concluded that FOD during panic attacks may distinguish non-fearful and fearful panic subgroups (Beitman et al., 1987) . Another study investigating the positive-feedback model of suicidality showed that FOD in PD mediated between suicidal ideation and suicide attempts in individuals with comorbid major depressive disorder, suggesting an indirect relationship between FOD and severe clinical outcomes (Yaseen, Chartrand, Mojtabai, Bolton, & Galynker, 2013). Other researchers have found that FOD, paresthesia, and choking are most often reported when a panic attack is severe (Ietsugu, Sukigara, & Furukawa, 2007) . However, no study has directly compared clinical differences between PD patients with FOD during panic attacks to those without this fear.
In the present report from the Rhode Island Methods to Improve Diagnostic Assessment and Services (MIDAS) project, we compared outpatients diagnosed with current PD who did and did not report FOD during their panic attacks. These groups were compared on variables indicating PD severity and variables indicating overall psychiatric impairment. We predicted that the presence of FOD during panic attacks would indicate a more severe clinical presentation of PD, defined by a higher frequency of PD as a primary diagnosis (i.e., the disorder for which the patient is seeking treatment), more frequent diagnosis of agoraphobia, a greater number of reported panic symptoms, a greater number of agoraphobic avoidances, an earlier age of PD-onset, a greater number of panic attacks within the past month, and higher subjective and somatic anxiety ratings. We also predicted that PD patients with FOD would exhibit higher-risk psychiatric morbidity, compared to PD patients without FOD, such as a greater number of comorbid Axis I disorders, hospitalizations, more severe suicidal ideation, a greater number of lifetime suicide attempts, and increased impairment in social and occupational functioning. Although it is counterintuitive to predict that those whom experience FOD would be at greater risk for suicide, there is indirect evidence linking fearful cognitions and FOD with suicidality (Goodwin & Hamilton, 2002; Yaseen et al., 2013) . Moreover, it is plausible for an individual to fear dying from a heart attack during a panic attack while concomitantly wishing for death more generally, or less unexpectedly, as a function of a depressive disorder. Therefore, we felt this was an appropriate prediction of psychiatric impairment, regardless of the conceptual overlap with the panic symptom in question.
METHODS

Sample
The current study examined a sample of 331 outpatients meeting DSM-IV criteria for current panic disorder. This was a subset drawn from a larger sample of 3,800 outpatients presenting for treatment at Rhode Island Hospital's Department of Psychiatry. The current sample only included patients who met DSM-IV criteria for current panic disorder with agoraphobia or current panic disorder without agoraphobia. Within this subset, the majority of the sample was female (n= 205; 61.9%), Caucasian (n= 299; 90.3%), married or never married (n=228; 68.9%), and had a high school degree or some college (193; 58.3%; see table 1). were observed administering 15-20. As a part of diagnostic training, the ratings for each item were reviewed for reliability between the senior diagnostician and the trainee. Trainees were then required to demonstrate exact (or near exact) reliability with the senior diagnostician on five consecutive interviews following the initial 20 (Zimmerman & Mattia, 1999) . Joint-interview reliability evaluations were conducted over the course of the project and have demonstrated excellent reliability for mood and anxiety disorders (Dalrymple & Zimmerman, 2007 ).
Procedure
Measures
A modified version of the Structured Clinical Interview for DSM-IV (SCID-IV; First et al., 1996) was used to diagnose current panic disorder and other Axis I disorders. We defined principal diagnosis as the disorder for which the patient was seeking treatment. In addition to diagnoses, we collected the following variables using the SCID: demographic characteristics, panic attack symptoms, agoraphobia symptoms, psychiatric hospitalizations, and lifetime suicide attempts. Diagnosticians measured the following variables using the Schedule for Affective Disorders and Schizophrenia (SADS: Spitzer 1977): current suicidal ideation (past two weeks), subjective anxiety symptoms (past week), somatic anxiety symptoms (past week), and past (adolescent) psychosocial functioning. Time out of work (in the past 5 years) was rated by diagnosticians on a Likert scale ranging from 0 (not expected to work) to 9 (worked none or practically none due to psychopathology). Patients not expected to work (e.g., student, disability, etc.) were excluded from this analysis. Out of work ratings were merged into two categories: "virtually no time" out of work versus "up to 1 month" or more out of work. Past psychosocial functioning was rated by diagnosticians on Likert scales ranging from 1 (superior) to 7 (grossly inadequate). Past psychosocial functioning ratings were merged into two categories: "fair" or worse and "good" or better. Current suicidal ideation and subjective and somatic anxiety symptoms were also merged into two categories: "none" through "mild" and "moderate" through "extreme." Diagnosticians rated overall clinical impairment using the Global Assessment of Functioning Scale (GAF). It should be noted that the aforementioned diagnoses, panic symptom, and other variables were obtained based on retrospective self-reports.
Statistical Analyses
The sample was divided into two groups based on the presence or absence of reported Comorbidity rates across various diagnostic categories were also compared between FOD groups. Contrary to our expectations, the two groups did not differ on SADS ratings on subjective or somatic anxiety within the past week, number of Axis I diagnoses, number of lifetime psychiatric hospitalizations, suicidal ideation, suicide attempts, GAF, past social functioning, or time out of work (see table 3 ). Additionally, PD patients with FOD did not have significantly higher rates of comorbidity with specific diagnostic categories, such as anxiety disorders, mood disorders, and substance use disorders, compared to PD patients without FOD (see table 4 ).
RESULTS
Out
We considered the possibility that we did not detect differences in psychiatric impairment and comorbidity between groups because we examined all patients with PD, and not just those with PD as a principal diagnosis. We repeated the analyses on the subsample of patients in each group with a principal diagnosis of PD. A significantly greater number of principal PD patients with FOD had one or more psychiatric inpatient hospitalization (13.0%), compared to principal PD patients without FOD (1.9% ; X 2 =6.21, p<0.05).
DISCUSSION
Patients with FOD during their panic attacks were more frequently diagnosed with PD as their principal diagnosis (i.e., the diagnosis for which they are seeking treatment), were more frequently diagnosed with agoraphobia, reported more symptomatic panic attacks, more agoraphobic avoidance behaviors, and an earlier age of onset, compared to PD patients who do not experience FOD. Despite differing in both diagnosis and symptomatology, there were no significant differences between groups on comorbidity or psychiatric impairment, such as number of additional Axis I diagnoses, suicidal ideation, number of lifetime suicide attempts, psychiatric hospitalizations, past social functioning, and time out of work due to psychopathology.
The current study extends past evidence that links cognitive symptoms of PD to a greater number of panic symptoms and agoraphobic behaviors by suggesting that such differences can be detected from the presence of a single cognitive feature. The present findings also reveal a potential relationship between FOD and panic attack intensity, which is consistent with past evidence that FOD is reported more often when panic attacks are severe. Given that significantly more patients with FOD were seeking treatment primarily for PD (as opposed to another disorder), compared to patients without this symptom, FOD may be positively associated with subjective distress in panic. Additionally, finding that a single cognitive feature is related to PD-severity corroborates recent critiques that current DSM-5 descriptions of PD place inadequate emphasis on cognitive-behavioral models of PD, compared to neurobiological explanations (Asmundson, Taylor, & Smits, 2014) .
Consistent with past research, the present study found that PD patients experiencing FOD were more frequently diagnosed with PDA (as opposed to PDWA), compared to the no-fear group.
Additionally, among agoraphobic patients in both groups, those with FOD reported significantly more agoraphobic avoidance behaviors than those without FOD. These results further elucidate the relationship between agoraphobia and catastrophic cognitions by suggesting that the presence of FOD alone may be an important contributor to the development and maintenance of agoraphobia, rather than cognitive symptoms more generally. Furthermore, our finding that FOD was related to more frequent agoraphobia diagnoses and a greater number of agoraphobia symptoms suggests that individuals with PD and comorbid agoraphobia may fear the consequences of panic symptoms (i.e., dying), rather just the panic symptoms themselves. This serves to extend recent criticism of DSM-5's guideline that "cognitive ideation" (e.g., feared consequences) distinguishes specific phobia from agoraphobia (Asmundson et al., 2014) .
Contrary to our expectations, and despite the aforementioned differences between the groups, the FOD-groups did not differ in comorbidity (e.g., additional diagnoses, number of comorbid anxiety disorders etc.) or psychiatric impairment (e.g., lifetime suicide attempts, psychiatric hospitalizations etc.). In a sample of patients presenting for treatment, comorbidity with other psychiatric disorders is the rule rather than the exception. Comorbid disorders also result in psychosocial morbidity, thereby possibly masking differences between PD patients with and without FOD. Too few patients were diagnosed with PD as their only disorder to examine the importance of FOD in a "pure" PD sample.
We reanalyzed these variables with a subsample of patients who were seeking treatment primarily for PD (i.e., a principal diagnosis of PD). With the exception of past psychiatric hospitalizations, no significant differences in psychiatric impairment or comorbidity were observed between FOD groups with PD as a primary diagnosis. However, even this subsample may have wide variability in comorbidity that could influence results related to psychiatric impairment. Future research that uses a "pure" PD sample that controls for comorbidity may provide insight into impairment differences based on FOD.
Interestingly, there were significantly more Hispanic patients in the FOD group. There is evidence that panic symptoms are conceptualized and reported differently between cultural groups The current study's findings should be understood in the context of certain limitations. We did not directly measure patients' subjective panic attack intensity, and therefore the any difference in panic attack intensity between these groups can only be inferred from differences in reported panic symptoms. Patient's retrospective self-reports during diagnostic interviews may be subject to bias. For instance, one study has indicated that patients report a greater number of panic-symptoms during retrospective self-reports, compared to self-monitoring (Margraf, et al., 1987 ), suggesting overreporting bias is more likely during diagnostic interviews. Moreover, patients in the present study may have experienced fear of dying with differing frequencies. Finally, we did not control for the other cognitive symptoms (i.e., fear of losing control or going crazy) because this would have left us with too few patients with FOD only. Therefore, the degree to which we can attribute these findings to the presence of FOD alone is limited. 
Conclusions
The current findings bolster existing evidence that catastrophic cognitions during panic attacks are associated with severity of PD symptoms. The current study extends this notion by finding that patients with a single cognitive feature of panic experience more panic symptoms and more subjective distress. As a result, FOD may be a detector of more severe PD pathology and increased treatment seeking for PD. However, more evidence is needed to strengthen this conclusion. The present findings and future work on the role of FOD in PD may assist researchers and clinicians in quickly identifying patients experiencing severe panic attacks or greater distress related to PD. 
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